Publications by authors named "Sonia Carriqui-Arenas"
Background: To assess the psychosocial impact of moderate-severe juvenile idiopathic arthritis (JIA) on patients and their families, among those who had been treated with at least one anti-tumor necrosis factor (anti-TNF-α), according to routine clinical practice in Spain.
Patients And Methods: A 24-month observational, multicentric, cross-sectional and retrospective study was performed. Children diagnosed with JIA were enrolled at three tertiary-care Spanish hospitals.
Background: Juvenile Dermatomyositis (JDM) is the most common chronic idiopathic inflammatory myopathy in children. The diagnosis is clinical. Baseline laboratory and complementary studies trace the phenotype of these patients.
View Article and Find Full Text PDFArticle Synopsis
- Juvenile idiopathic arthritis (JIA) is a common chronic condition in children that can lead to serious long-term issues if not properly treated, highlighting the need for early intervention.
- A study in Spain assessed the costs associated with moderate-to-severe JIA in children, including both direct costs (like medication and doctor visits) and indirect costs (like travel and lost work hours for caregivers).
- Results showed that the average annual cost for treating JIA was €7516.40, with medication being the largest expense, mostly consisting of biologic treatments like adalimumab and etanercept.